Trial intelligence / Profile preview

Explorative study on biological mechanisms in psoriasis (LL37-specific T cells and p40 inhibition)

2017-002012-13Phase 3Completed

Sponsor
Humanitas Research Hospital
Start
Jan 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ustekinumab, methotrexate in psoriasis, sponsored by Humanitas Research Hospital. Started Jan 2021; status: completed.

02

Drugs

ustekinumabmethotrexate
03

Conditions

psoriasis

Beyond the preview

Go deeper on 2017-002012-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-002012-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call